Barry J. Simon - 20 Jun 2024 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Reporting relationship: Director
Issuer ticker: VIRX
Reported as of: 20 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jun 2024, 19:44:18 UTC
Prior SEC filing: 26 Feb 2024
Next SEC filing: 24 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael E. Faerm, Power of Attorney

Key filing fact

Barry J. Simon filed Form 4 for Viracta Therapeutics, Inc. (VIRX) on 24 Jun 2024.

Key facts

This page summarizes Barry J. Simon's Form 4 filing for Viracta Therapeutics, Inc. (VIRX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Jun 2024, 19:44.

Change

Previous filing in this sequence was filed on 26 Feb 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIRX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +50,000
Change %
Price: $0.000000
Shares after: 50,000
Date: 20 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $0.5690
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date.

SEC remarks

Exhibit 24: Power of Attorney